A highly precise type of radiotherapy called intensity-modulated radiation therapy (IMRT) may be a safer form of treating lymph nodes in patients with prostate cancer, a clinical trial report suggests. Read more read more →

First described in a paper published 4 years ago, the new Gleason grade group system for the risk classification of prostate cancer (PCa) is now routinely included in PCa pathology reports and commonly used in counseling patients newly diagnosed with the malignancy. Read more read more →

LOWELL — Week after week, the man battling prostate cancer visits the hospital for conventional radiation therapy. The grueling, marathon treatment plan stretches for more than two months. Read more read more →

Although about 1 in 7 men will be eventually be diagnosed with prostate cancer in his lifetime, the warning signs of the disease are often vague and may be confused with other conditions, experts at Fox Chase Cancer Center say. Read more read more →

Andrew J. Armstrong, MD, associate professor of medicine and surgery, Department of Medicine, Duke University School of Medicine, discusses precision medicine for patients with metastatic prostate cancer. Read more read more →